Mark Hasleton
Nessuna posizione attualmente
Profilo
Mark Hasleton worked as a Senior Director-Global New Therapeutic Entities at Teva Pharmaceutical Industries Ltd.
from 2010 to 2018.
He also worked as a Manager-EMEA Business Operations at Bristol Myers Squibb Co. He then worked as a Vice President-Business Development at Oramed Pharmaceuticals, Inc. from 2018 to 2019.
Dr. Hasleton holds a doctorate from Imperial College London, a graduate degree from The University of Manchester, and an MBA from Imperial College Business School.
Precedenti posizioni note di Mark Hasleton
| Società | Posizione | Fine |
|---|---|---|
| ORAMED PHARMACEUTICALS INC. | Corporate Officer/Principal | 27/08/2019 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/01/2018 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Formazione di Mark Hasleton
| Imperial College London | Doctorate Degree |
| The University of Manchester | Graduate Degree |
| Imperial College Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ORAMED PHARMACEUTICALS INC. | Health Technology |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
- Borsa valori
- Insiders
- Mark Hasleton
